Dimitrios Moris | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Dimitrios Moris | Medicine and Dentistry | Best Researcher Award

MD, MSc, PhD at Georgetown University, United States

Dr. Dimitrios Paraskevas Moris is an accomplished surgeon and researcher with a focus on abdominal multi-organ transplantation and hepatopancreatobiliary (HPB) surgery. He is currently completing a fellowship at MedStar Georgetown University, Washington DC, in abdominal and multivisceral transplantation. With a robust academic background, Dr. Moris has worked in multiple prestigious institutions, including Duke University and Ohio State University, where he specialized in various research fellowships. His professional interests encompass liver transplantation, pancreatic surgery, and aortic aneurysm research. In addition to his clinical training, Dr. Moris has received several scholarships and awards, affirming his excellence in both research and practice. His career trajectory demonstrates a deep commitment to advancing medical knowledge, particularly in the fields of transplantation and surgery, where he applies his diverse expertise to patient care and scientific advancement.

Professional Profile

Education:

Dr. Moris holds an extensive educational background that spans multiple degrees and prestigious institutions. He completed his M.D. at the National and Kapodistrian University of Athens in 2010, graduating with distinction. He later pursued a Ph.D. in the same university, focusing on the role of serum calprotectin in abdominal aortic aneurysm development, for which he earned unanimous excellent recognition. Dr. Moris also holds an MSc in Endovascular Techniques from the National and Kapodistrian University of Athens, complementing his extensive academic training. Throughout his career, he has further advanced his expertise through fellowships at renowned institutions like Ohio State University, Duke University, and MedStar Georgetown University, where he currently holds a fellowship in abdominal transplantation and HPB surgery.

Professional Experience:

Dr. Moris’ professional experience is marked by his diverse roles in academia and clinical practice. He currently serves as a fellow in abdominal and multivisceral transplantation and hepatopancreatobiliary surgery at MedStar Georgetown University Hospital. Prior to this, he completed a general surgery residency at Duke University Medical Center, where he also worked as a research fellow. His experience includes significant time spent as a research fellow at Ohio State University and Cleveland Clinic Foundation, contributing to cutting-edge research in liver transplantation and cancer treatment. His clinical experience spans multiple prestigious institutions, where he trained and practiced in general surgery, transplantation, and vascular surgery, including the Laikon General Hospital in Athens, Greece.

Research Interests:

Dr. Moris’ research interests are concentrated on the intersection of transplantation, surgical oncology, and vascular surgery. He has explored aortic aneurysm repair, particularly focusing on the comparison between open and endovascular techniques. His Ph.D. research on serum calprotectin’s role in abdominal aortic aneurysm development exemplifies his dedication to understanding complex mechanisms in surgical pathology. Additionally, Dr. Moris has contributed extensively to the fields of liver transplantation and hepatopancreatobiliary surgery, researching novel therapeutic approaches and techniques to improve patient outcomes. His interests also extend to cancer research, especially the management of hepatocellular carcinoma and related oncological conditions.

Research Skills:

Dr. Moris possesses advanced research skills honed through extensive experience in high-level academic settings. He is proficient in experimental design, data analysis, and scientific writing, with numerous publications in top-tier medical journals. His research methodology includes both clinical and laboratory-based approaches, with particular expertise in translational research related to transplantation and surgical oncology. Dr. Moris is skilled in using advanced statistical tools and is adept at conducting complex surgeries and post-operative care in research settings. His collaborative nature and extensive mentorship from renowned researchers have enabled him to contribute to significant scientific discoveries and advancements in the fields of surgery and transplantation.

Awards and Honors:

Dr. Moris has received numerous awards and honors throughout his career, reflecting his outstanding contributions to medicine and surgery. Notable accolades include the Dr. Robert W. Kieffer Best Research Paper Award, the ABSITE Examination Excellence Award, and the Surgical Autonomy Program Evaluation Award. In addition to his clinical achievements, Dr. Moris has been recognized for his research excellence with prestigious scholarships, including the Alexander S. Onassis Foundation Scholarship and the Thorax Foundation Scholarship for postdoctoral research. He is also a member of the Sigma Xi Scientific Research Honor Society and has received multiple leadership and teaching awards, further underscoring his multifaceted contributions to the medical field. These honors highlight his dedication to advancing surgical practice and medical research.

Conclusion:

Dimitrios Paraskevas Moris exemplifies the qualities of a top-tier researcher with substantial expertise, impactful publications, leadership recognition, and a global research presence. His consistent contribution to medical research, particularly in surgery and transplantation, paired with his dedication to advancing clinical practices, makes him a strong candidate for the Best Researcher Award. Further exploration of interdisciplinary research and collaboration could further solidify his place as a leading figure in his field.

Publication Top Notes

  • Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
    • Authors: COVIDSurg Collaborative
    • Year: 2021
    • Citations: 425
    • Journal: Anaesthesia, 76(6), 748-758
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
    • Authors: D Dimitroulis, C Damaskos, S Valsami, S Davakis, N Garmpis, E Spartalis, …
    • Year: 2017
    • Citations: 364
    • Journal: World Journal of Gastroenterology, 23(29), 5282
  • Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
    • Authors: CCGS Collaborative
    • Year: 2021
    • Citations: 298*
    • Journal: Anaesthesia
  • Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
    • Authors: J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, …
    • Year: 2021
    • Citations: 266
    • Journal: The Lancet Oncology, 22(11), 1507-1517
  • The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox
    • Authors: D Moris, M Spartalis, E Spartalis, GS Karachaliou, GI Karaolanis, …
    • Year: 2017
    • Citations: 263
    • Journal: Annals of Translational Medicine, 5(16)
  • Diagnosis and management of acute appendicitis in adults: a review
    • Authors: D Moris, EK Paulson, TN Pappas
    • Year: 2021
    • Citations: 261
    • Journal: JAMA, 326(22), 2299-2311
  • Amyand’s hernia: a review
    • Authors: A Michalinos, D Moris, S Vernadakis
    • Year: 2014
    • Citations: 258
    • Journal: The American Journal of Surgery, 207(6), 989-995
  • Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
    • Authors: D Moris, M Palta, C Kim, PJ Allen, MA Morse, ME Lidsky
    • Year: 2023
    • Citations: 212
    • Journal: CA: A Cancer Journal for Clinicians, 73(2), 198-222
  • Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer
    • Authors: C Damaskos, S Valsami, M Kontos, E Spartalis, T Kalampokas, …
    • Year: 2017
    • Citations: 208
    • Journal: Anticancer Research, 37(1), 35-46
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review
    • Authors: DI Tsilimigras, I Ntanasis-Stathopoulos, F Bagante, D Moris, J Cloyd, …
    • Year: 2018
    • Citations: 178
    • Journal: Surgical Oncology, 27(2), 280-288

Royston Liew | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623